Integrative Molecular Characterization of Malignant Pleural Mesothelioma
Open accessPublished version of a preprint
The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Abstract Malignant pleural mesothelioma (MPM) is a highly lethal cancer of the lining of the chest cavity. To expand our understanding of MPM, we conducted a comprehensive integrated genomic study, including the most detailed analysis of BAP1 alterations to date. We identified histology-independent molecular prognostic subsets, and defined a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity. We also report strong expression of the immune-checkpoint gene VISTA in epithelioid MPM, strikingly higher than in other solid cancers, with implications for the immune response to MPM and for its immunotherapy. Our findings highlight new avenues for further investigation of MPM biology and novel therapeutic options. Significance: Through a comprehensive integrated genomic study of 74 MPMs, we provide a deeper understanding of histology-independent determinants of aggressive behavior, define a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity, and discovered strong expression of the immune-checkpoint gene VISTA in epithelioid MPM. See related commentary by Aggarwal and Albelda, p. 1508. This article is highlighted in the In This Issue feature, p. 1494
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, a study that explored 74 mesothelioma tumors using a genomic analysis identified TGF-β1 mRNA expression as being correlated with the worst patient prognoses [40].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Absolute quantification of somatic DNA alterations in human cancer
Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,053
Self-citationThe Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443 · cited 1×
“Since MPM with evidence of GNH have typically undergone a genome-doubling event, we were able to assess the timing of this relative to point mutations (30,31).”
BackgroundSelf-citationSomatic mutation in cancer and normal cells
Martincorena, I., & Campbell, P. J. (2015) · Science · doi:10.1126/science.aab4082 · Cited by 1,396 · cited 1×
“This places MPM at the low end of somatic mutation burden among cancers (8).”
BackgroundSelf-citationShen, R., & Seshan, V. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw520 · Cited by 1,258
Self-citationBroz, M. L., Binnewies, M., Boldajipour, B., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A., Rosenblum, M. D., Daud, A., Barber, D. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.007 · Cited by 1,207
Clock-like mutational processes in human somatic cells
Alexandrov, L. B., Jones, P. H., Wedge, D. C., Sale, J. E., Campbell, P. J., Nik-Zainal, S., & Stratton, M. R. (2015) · Nature Genetics · doi:10.1038/ng.3441 · Cited by 1,058
Self-citationBueno, R., Stawiski, E. W., Goldstein, L. D., Durinck, S., De Rienzo, A., Modrusan, Z., Gnad, F., Nguyen, T. T., Jaiswal, B. S., Chirieac, L. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3520 · Cited by 919
Self-citationShen, R., Olshen, A. B., & Ladanyi, M. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp543 · Cited by 849 · cited 1×
“To find out whether multi-platform molecular profiling might provide additional resolution to define prognostic subsets of MPM, we performed integrative clustering across multiple assay platforms using two algorithms: iCluster (32) and PARADIGM (33).”
MethodSelf-citationVaske, C. J., Benz, S. C., Sanborn, J. Z., Earl, D., Szeto, C., Zhu, J., Haussler, D., & Stuart, J. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq182 · Cited by 786
Self-citation
Cited by
Items 201–300 of 675
Ma, S., Chee, J., Fear, V. S., Forbes, C. A., Boon, L., Dick, I. M., Robinson, B. W. S., & Creaney, J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1684714 · Cited by 20
Self-citationVlačić, G., Hoda, M. A., Klikovits, T., Sinn, K., Gschwandtner, E., Mohorčič, K., Schelch, K., Pirker, C., Peter‐Vörösmarty, B., Brankovic, J., et al. (2019) · Cells · doi:10.3390/cells8091091 · Cited by 19
Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
Wadowski, B. J., Bueno, R., & Rienzo, A. D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.684025 · Cited by 19
Self-citationImmunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream
Calabrò, L., Bronte, G., Grosso, F., Cerbone, L., Delmonte, A., Nicolini, F., Mazza, M., Giacomo, A. M. D., Covre, A., Lofiego, M. F., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1333661 · Cited by 19
Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma
Hjerpe, A., Own, S. A., & Dobra, K. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-2019-pps-10 · Cited by 19
Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes
Markowitz, P., Patel, M. M., Groisberg, R., Aisner, J., Jabbour, S. K., De, S., Ganesan, S., & Malhotra, J. D. (2020) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2020.100232 · Cited by 19
Multimodality Therapy in Patients With Primary Pericardial Mesothelioma
Offin, M. D., Silva, D. L. D., Sauter, J. L., Egger, J. V., Yorke, E. D., Adusumilli, P. S., Rimner, A., Rusch, V. W., & Zauderer, M. G. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.08.017 · Cited by 19
Self-citationMolecular Characterization of Malignant Mesothelioma: Time for New Targets?
Aggarwal, C., & Albelda, S. Μ. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1181 · Cited by 19
Busacca, S., O’Regan, L., Singh, A., Sharkey, A. J., Dawson, A. G., Działo, J., Parsons, A., Kumar, N., Schunselaar, L. M., Guppy, N., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0363 · Cited by 19
The RB protein: more than a sentry of cell cycle entry
Thangavelu, P. U., Lin, C., Forouz, F., Tanaka, K., Dray, E. V., & Duijf, P. H. G. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.04.001 · Cited by 18
POLR1A inhibits ferroptosis by regulating TFAM-mediated mitophagy and iron homeostasis
Zhang, T., Gao, Y., Harhai, M., Jourdain, A. A., Marti, T. M., Vassella, E., Zhang, Y., Zhou, Q., Dorn, P., & Peng, R. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103758 · Cited by 18
Yang, H., Xu, D., Zhang, Y., Yao, F., Zhao, H., Schmid, R. A., & Peng, R. (2020) · Cancers · doi:10.3390/cancers12082310 · Cited by 18
Sementino, E., Kadariya, Y., Cheung, M., Menges, C. W., Tan, Y., Kukuyan, A.-M., Shrestha, U., Karchugina, S., Cai, K. Q., Peri, S., et al. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0837 · Cited by 18
Rasmussen, M. Q., Tindbæk, G., Nielsen, M. M., Merrild, C., Steiniche, T., Pedersen, J. S., Moestrup, S. K., Degn, S. E., & Madsen, M. M. (2023) · Cancers · doi:10.3390/cancers15061830 · Cited by 18
The Current Treatment Landscape of Malignant Pleural Mesothelioma and Future Directions
Bertin, B., Zugman, M., & Schvartsman, G. (2023) · Cancers · doi:10.3390/cancers15245808 · Cited by 18
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma
Landman, N., Hulsman, D., Badhai, J., Kopparam, J., Puppe, J., Pandey, G. K., & van Lohuizen, M. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02661-3 · Cited by 18
Pathology of Malignant Pleural Mesothelioma
Hung, Y. P., & Chirieac, L. R. (2020) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2020.08.007 · Cited by 18
Self-citationAsbestos and Zeolites: from A to Z via a Common Ion
Reid, G., Klebe, S., van Zandwijk, N., & George, A. M. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00286 · Cited by 18
Self-citationKresoja‐Rakic, J., Szpechciński, A., Kirschner, M. B., Ronner, M., Minatel, B. C., Martínez, V. D., Lam, W. L., Weder, W., Stahel, R. A., Früh, M., et al. (2019) · Non-Coding RNA · doi:10.3390/ncrna5020041 · Cited by 18
Advances in pathological diagnosis of mesothelioma: what pulmonologists should know
Louw, A., Badiei, A., Creaney, J., Chai, M., & Lee, G. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000578 · Cited by 18
Self-citationZhang, Y. Z., Brambilla, C., Molyneaux, P. L., Rice, A. J., Robertus, J. L., Jordan, S. J., Lim, E. K. S., Lang-Lazdunski, L., Begum, S., Dusmet, M. E., et al. (2020) · Histopathology · doi:10.1111/his.14127 · Cited by 18
Self-citationCampanella, N. C., da Silva, E. C. A., Pinto, G. D. J., Vazquez, F. D. L., de Paula, F. E., Berardinelli, G. N., Balancin, M. L., Chammas, R. J., López, R. V. M., Silveira, H. C. S., et al. (2020) · Pathobiology · doi:10.1159/000507373 · Cited by 18
Self-citationFernandez‐Cuesta, L., Mangiante, L., Alcala, N., & Foll, M. (2021) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-020-02980-9 · Cited by 18
Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
Terenziani, R., Zoppi, S., Fumarola, C., Alfieri, R. R., & Bonelli, M. A. (2021) · Cancers · doi:10.3390/cancers13112793 · Cited by 18
Severson, D. T., Freyaldenhoven, S. T., Wadowski, B. J., Hung, Y. P., Hughes, T. K., Yeap, B. Y., Richards, W. G., Laaksonen, S., Chirieac, L. R., Couger, M. B., et al. (2025) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2025.11.019 · Cited by 19
Self-citationNel, A. E., Pavlisko, E. N., & Roggli, V. L. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.11.017 · Cited by 18
Shi, M., Wang, Y., Tang, W., Cui, X., Wu, H. J., Tang, Y., Wang, P., Wu, W., & Zhang, H. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.98 · Cited by 17
Self-citationLapidot, M., Case, A. E., Weisberg, E., Meng, C., Walker, S. R., Garg, S., Wei Min, N. I., Podar, K., Hung, Y. P., Carrasco, R. D., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01441-7 · Cited by 17
Self-citationOsmanbeyoglu, H. U., Palmer, D., Sagan, A., Sementino, E., Becich, M. J., & Testa, J. R. (2022) · Cancers · doi:10.3390/cancers14225626 · Cited by 17
Self-citationBarnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., Shaw, L., Silva, L. C., Goate, Z., Marciniak, S. J., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0635 · Cited by 17
Self-citationTatemoto, P., Pértille, F., Bernardino, T., Zanella, R., Guerrero‐Bosagna, C., & Zanella, A. J. (2023) · Epigenetics · doi:10.1080/15592294.2023.2196656 · Cited by 18
Cedrés, S., Ponce-Aix, S., Iranzo, P., Callejo, A., Pardo, N., Navarro, A., Martínez‐Martí, A., Gómez-Abecia, S., Zucchiatti, A., Sansano, I., et al. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02275-9 · Cited by 17
Cytogenomic characterization of three murine malignant mesothelioma tumor cell lines
Wahlbuhl, E., Liehr, T., Rinčić, M., & Azawi, S. S. H. (2020) · Molecular Cytogenetics · doi:10.1186/s13039-020-00511-4 · Cited by 16
Benzerdjeb, N., Dartigues, P., Képénékian, V., Damiola, F., Sequeiros, R., Galateau-Sallé, F., Bégueret, H., Mery-Lamarche, E., Damotte, D., Verrièle, V., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103644 · Cited by 16
Self-citationNader, J. S., Boissard, A., Henry, C., Valo, I., Verrièle, V., Grégoire, M., Coqueret, O., Guette, C., & Pouliquen, D. (2020) · Cancers · doi:10.3390/cancers12092430 · Cited by 16
Circulating biomarkers in malignant pleural mesothelioma
Viscardi, G., Natale, D. D., Fasano, M., Brambilla, M., Lobefaro, R., Toma, A. D., & Galli, G. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00028 · Cited by 16
Naso, J. R., Tessier‐Cloutier, B., Senz, J., Huntsman, D. D., & Churg, A. (2021) · Modern Pathology · doi:10.1038/s41379-021-00920-9 · Cited by 16
Current Management and Future Perspective in Pleural Mesothelioma
Shah, R., Klotz, L. V., & Glade, J. (2022) · Cancers · doi:10.3390/cancers14041044 · Cited by 16
DNA repair and damage pathways in mesothelioma development and therapy
Malakoti, F., Targhazeh, N., Abadifard, E., Zarezadeh, R., Samemaleki, S., Asemi, Z., Younesi, S., Mohammadnejad, R., Hossini, S. H., Karimian, A., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02597-9 · Cited by 16
Roshini, A., Goparaju, C. M. V., Kundu, S., Nandhu, M. S., Longo, S. L., Longo, J. A., Chou, J., Middleton, F. A., Pass, H. I., & Viapiano, M. S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1014749 · Cited by 16
Self-citationTorricelli, F., Donati, B., Reggiani, F., Manicardi, V., Piana, S., Valli, R., Lococo, F., & Ciarrocchi, A. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01816-9 · Cited by 16
Xu, D., Yang, H., Schmid, R. A., & Peng, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.579464 · Cited by 16
P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment
Pezzuto, F., Lunardi, F., Vedovelli, L., Fortarezza, F., Urso, L., Grosso, F., Ceresoli, G. L., Kern, I., Vlačić, G., Faccioli, E., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653497 · Cited by 16
Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors
Lin, X., Xiao, M., Chen, Z., Ding, C., Zhang, T., & Li, Q. (2022) · Journal of Oncology · doi:10.1155/2022/6115878 · Cited by 16
Non-asbestiform elongate mineral particles and mesothelioma risk: Human and experimental evidence
Goodman, J. E., Becich, M. J., Bernstein, D. M., Case, B. W., Mandel, J. H., Nel, A. E., Nolan, R., Odo, N. U., Smith, S. R., Taioli, E., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2022.114578 · Cited by 15
Self-citationAkao, K., Sato, T., Mishiro‐Sato, E., Mukai, S., Ghani, F. I., Kondo‐Ida, L., Imaizumi, K., & Sekido, Y. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0308 · Cited by 15
Self-citationMolecular characterization of pleomorphic mesothelioma: a multi-institutional study
Roy, S., Galateau-Sallé, F., Stang, N. L., Churg, A., Lyons, M. A., Attanoos, R. L., & Đačić, S. (2021) · Modern Pathology · doi:10.1038/s41379-021-00900-z · Cited by 15
Self-citationAgaimy, A., Brčić, L., Briski, L. M., Hung, Y. P., Michal, M., Michal, M., Nielsen, G. P., Stoehr, R., & Rosenberg, A. E. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23118 · Cited by 15
Chu, G. J., Linton, A., Kao, S., Klebe, S., Adelstein, S., Yeo, D., Rasko, J. E. J., & Cooper, W. A. (2023) · Histopathology · doi:10.1111/his.14916 · Cited by 15
Impact of Operation on Disease Progression and Survival of Patients With Pleural Mesothelioma
Nakamura, A., Hashimoto, M., Kuroda, A., Matsumoto, S., Kondo, N., Kitajima, K., Minami, T., Kuribayashi, K., Kijima, T., & Hasegawa, S. (2024) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2024.02.022 · Cited by 15
Self-citationIs DNA repair a potential target for effective therapies against malignant mesothelioma?
Nerini, I. F., Roca, E., Mannarino, L., Grosso, F., Frapolli, R., & D’Incalci, M. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102101 · Cited by 15
Esteves, L., Caramelo, F. J., Ribeiro, I. P., Carreira, I. M., & Melo, J. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-71859-1 · Cited by 15
Popat, S., Sharma, B., MacMahon, S., Nicholson, A. G., Sharma, R. K., Schuster, K., Lazdunski, L. L., & Fennell, D. A. (2021) · JCO Precision Oncology · doi:10.1200/po.20.00260 · Cited by 15
Wirawan, A., Tajima, K., Takahashi, F., Mitsuishi, Y., Winardi, W., Hidayat, M., Hayakawa, D., Matsumoto, N., Izumi, K., Asao, T., et al. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0230 · Cited by 15
Self-citationYang, H., Berezowska, S., Dorn, P., Zens, P., Chen, P., Peng, R., Marti, T. M., Kocher, G. J., Schmid, R. A., & Hall, S. R. R. (2021) · Theranostics · doi:10.7150/thno.61209 · Cited by 15
Singh, A., Busacca, S., Gaba, A., Sheaff, M. T., Poile, C., Nakas, A., Działo, J., Bzura, A., Dawson, A. G., Fennell, D. A., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02577-3 · Cited by 15
Li, Y., Yang, S., Chen, Y., Adusumilli, P. S., Bialik, A., Bodd, F. M., Ladanyi, M., Lopardo, J., Offin, M. D., Rusch, V. W., et al. (2023) · Modern Pathology · doi:10.1016/j.modpat.2022.100030 · Cited by 15
Self-citationOwn, S. A., Höijer, J., Hillerdahl, G., Dobra, K., & Hjerpe, A. (2020) · Diagnostic Cytopathology · doi:10.1002/dc.24395 · Cited by 15
Sato, H., Ito, T., Hayashi, T., Kitano, S., Erdjument‐Bromage, H., Bott, M. J., Toyooka, S., Zauderer, M. G., & Ladanyi, M. (2024) · Oncogene · doi:10.1038/s41388-024-02966-w · Cited by 14
Self-citationYang, H., Gao, Y., Xu, D., Xu, K., Liang, S., Zhang, Y., Scherz, A., Hall, S. R. R., Forster, S., Berezowska, S., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01307-2 · Cited by 14
Diagnosis of Pleural Mesothelioma: Is Everything Solved at the Present Time?
Roca, E., Aujayeb, A., & Astoul, P. J. (2024) · Current Oncology · doi:10.3390/curroncol31090368 · Cited by 14
Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?
Gao, Y., Julio, M. K., Peng, R., & Dorn, P. (2022) · Cancers · doi:10.3390/cancers14153758 · Cited by 14
The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
Borgeaud, M., Kim, F., Friedlaender, A., Lococo, F., Addeo, A., & Minervini, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051757 · Cited by 14
Challenges in defining thresholds for health effects: some considerations for asbestos and silica
Goodman, J. E., Rhomberg, L. R., Cohen, S. M., Mundt, K. A., Case, B. W., Burstyn, I., Becich, M. J., & Gibbs, G. W. (2025) · Frontiers in Epidemiology · doi:10.3389/fepid.2025.1557023 · Cited by 13
Self-citationCunningham, R., Jia, S., Purohit, K. P., Nosková, M., Maniak, M. K., Lin, Y., Hui, N. S., Graham, R. E., Rossi, A. G., Cholewa-Waclaw, J., et al. (2025) · Life Science Alliance · doi:10.26508/lsa.202503241 · Cited by 13
Shinozaki‐Ushiku, A., Kohsaka, S., Kage, H., Oda, K., Miyagawa, K., Nakajima, J., Aburatani, H., Mano, H., & Ushiku, T. (2020) · Pathology International · doi:10.1111/pin.12977 · Cited by 13
Self-citationThe Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma
Perera, N. D., & Mansfield, A. S. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01302-3 · Cited by 13
Cunningham, R., Jia, S., Purohit, K. P., Salem, O., Hui, N. S., Lin, Y., Carragher, N. O., & Hansen, C. G. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1190 · Cited by 13
Chmiel, P., Gęca, K., Michalski, A., Kłosińska, M., Kaczyńska, A., Polkowski, W. P., Pelc, Z., & Skórzewska, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129945 · Cited by 13
Castro, R. L., Fuentes-Martín, Á., del Valle, A. M., García-Peña, T., Soro-García, J., González, L. L., & Ramos, Á. C. (2024) · Open Respiratory Archives · doi:10.1016/j.opresp.2024.100323 · Cited by 13
Li, Y., Sun, B., Xu, L., Chen, L., & Ou, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147416 · Cited by 13
Sa-Ngiamwibool, P., Hamasaki, M., Kinoshita, Y., Matsumoto, S., Sato, A., Tsujimura, T., Kawahara, K., Kasai, T., Kushitani, K., Takeshima, Y., et al. (2022) · Lung Cancer · doi:10.1016/j.lungcan.2022.11.013 · Cited by 13
Self-citationBarnett, S. E., Herrmann, A., Shaw, L., Gash, E. N., Poptani, H., Sacco, J. J., & Coulson, J. M. (2022) · Cancers · doi:10.3390/cancers14235836 · Cited by 13
The Hippo signaling pathway: from multiple signals to the hallmarks of cancers
Zhu, N., Yang, R., Wang, X., Yuan, L., Li, X., Wei, F., & Zhang, L. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023035 · Cited by 13
Kanellakis, N. I., Asciak, R., Hamid, M. A., Yao, X., McCole, M., McGowan, S. J., Seraia, E., Hatch, S. B., Hallifax, R., Mercer, R., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-215027 · Cited by 13
Self-citationOffin, M. D., Aguirre, N., Yang, S., Sauter, J. L., Karagkounis, G., Mohamed, M. A., Cercek, A., Kundra, R., Zhang, Y., Wang, H. M., et al. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-16004-2 · Cited by 12
Self-citationFennell, D. A., Hill, K., Zhang, M., Poile, C., Ewings, S. M., Baitei, E. Y., Działo, J., Nusrat, N., Rogel, J., Faulkner, D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61691-4 · Cited by 12
Advances in Immunotherapy of Malignant Pleural Mesothelioma
Liao, D., Yu, Y., Mei, Q., Wang, Z., Li, X., Jia, Y., & Kong, F. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s317434 · Cited by 12
Self-citationClear cell mesotheliomas with inactivating VHL mutations and near‐haploid genomic features
Michal, M., Kravtsov, O., Ross, J. S., Škanderová, D., Martínek, P., Mosaieby, E., Mata, D. A., Williams, E. A., & Hung, Y. P. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23119 · Cited by 12
Cedrés, S., Valdivia, A., Iranzo, P., Callejo, A., Pardo, N., Navarro, A., Martínez‐Martí, A., Assaf-Pastrana, J. D., Felip, E., & Garrido, P. (2023) · Cancers · doi:10.3390/cancers15245787 · Cited by 12
Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments
Ma, X., Lembersky, D., Kim, E. S., Becich, M. J., Testa, J. R., Bruno, T. C., & Osmanbeyoglu, H. U. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0524 · Cited by 12
Self-citationChan, M., Wu, L., Yun, Z., McKee, T. D., Cabanero, M., Zhao, Y. D., Kohno, M., Murakami, J., & de Perrot, M. E. (2021) · Communications Biology · doi:10.1038/s42003-021-02430-5 · Cited by 12
The efficacy of immune checkpoint inhibitors in thoracic malignancies
Remón, J., Facchinetti, F., & Besse, B. (2021) · European Respiratory Review · doi:10.1183/16000617.0387-2020 · Cited by 12
The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma
Banerji, S. O., Meyers, D. E., Harlos, C. H., & Dawe, D. E. (2021) · Current Oncology · doi:10.3390/curroncol28060385 · Cited by 12
Louw, A., Vliet, C. V., Peverall, J., Colkers, S., Acott, N., Creaney, J., Lee, G., & Chai, S. M. (2022) · Cancer Cytopathology · doi:10.1002/cncy.22548 · Cited by 12
Self-citationTerenziani, R., Galetti, M., Monica, S. L., Fumarola, C., Zoppi, S., Alfieri, R. R., Digiacomo, G., Cavazzoni, A., Cavallo, D., Corradi, M., et al. (2022) · Cancers · doi:10.3390/cancers14235925 · Cited by 12
Antimesothelioma Immunotherapy by CTLA-4 Blockade Depends on Active PD1-Based TWIST1 Vaccination
Tan, Z., Chiu, M. S., Yan, C. W., Wong, Y. C., Huang, H., Man, K., & Chen, Z. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.01.009 · Cited by 12
Mahfuz, A. M. U. B., Zubair-Bin-Mahfuj, A. M., & Podder, D. J. (2021) · Genomics & Informatics · doi:10.5808/gi.21019 · Cited by 12
Current and future applications of artificial intelligence in lung cancer and mesothelioma
Roche, J. J., Seyedshahi, F., Rakovic, K., Thu, A. W., Le Quesne, J., & Blyth, K. G. (2025) · Thorax · doi:10.1136/thorax-2024-222054 · Cited by 11
CDKN2A deletion is associated with immune desertification in diffuse pleural mesothelioma
Torricelli, F., Donati, B., Manicardi, V., Gugnoni, M., Reggiani, F., Manzotti, G., Chiaro, P. D., Ascione, C., Piana, S., Valli, R., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03522-4 · Cited by 11
Pass, H. I., Alimi, M., Carbone, M., Yang, H., & Goparaju, C. M. V. (2020) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2020.08.001 · Cited by 11
Self-citationMannarino, L., Mirimao, F., Panini, N., Paracchini, L., Marchini, S., Beltrame, L., Amodeo, R., Grosso, F., Libener, R., Simone, I. D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05073-4 · Cited by 11
Zhu, R., Liu, X., Zhang, X., Zhong, Z., Qi, S., Jin, R., Gu, Y., Wang, Y., Chen, L., Chen, K., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101763 · Cited by 11
Kato, T., Tanaka, I., Huang, H., Okado, S., Imamura, Y., Nomata, Y., Takenaka, H., Watanabe, H., Kawasumi, Y., Nakanishi, K., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094299 · Cited by 11
Cedrés, S., Valdivia, A., Priano, I., Rocha, P., Iranzo, P., Pardo, N., Martínez‐Martí, A., & Felip, E. (2025) · Cancers · doi:10.3390/cancers17091581 · Cited by 11
Cyclin D1 immunohistochemical staining to separate benign from malignant mesothelial proliferations
Pors, J., Naso, J. R., Berg, K. B., & Churg, A. (2019) · Modern Pathology · doi:10.1038/s41379-019-0411-9 · Cited by 11
Çakılkaya, P., Soerensen, R., Jürgensen, H. J., Krigslund, O., Gårdsvoll, H., Nielsen, C., Santoni‐Rugiu, E., Behrendt, N., & Engelholm, L. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111452 · Cited by 11
A molecular phenotypic map of malignant pleural mesothelioma
Genova, A. D., Mangiante, L., Sexton‐Oates, A., Voegele, C., Fernandez‐Cuesta, L., Alcala, N., & Foll, M. (2022) · GigaScience · doi:10.1093/gigascience/giac128 · Cited by 11
Lund‐Andersen, C., Nakken, S., Nygård, S., Fromm, B., Aasheim, L. B., Davidson, B., Julsrud, L., Abrahamsen, T. W., Kristensen, A. T., Dybdahl, B., et al. (2019) · Molecular Case Studies · doi:10.1101/mcs.a003566 · Cited by 11
Survival correlation of immune response in human cancers
Liu, Y. (2019) · Oncotarget · doi:10.18632/oncotarget.27360 · Cited by 11
Metadata
- Authors
- Hmeljak, J., Sanchez-Vega, F., Hoadley, K. A., Shih, J., Stewart, C., Heiman, D., Tarpey, P., Danilova, L., Drill, E., Gibb, E. A., Bowlby, R., Kanchi, R., Osmanbeyoglu, H. U., Sekido, Y., Takeshita, J., Newton, Y., Graim, K., Gupta, M., Gay, C. M., Diao, L., Gibbs, D. L., Thorsson, V., Iype, L., Kantheti, H., Severson, D. T., Ravegnini, G., Desmeules, P., Jungbluth, A. A., Travis, W. D., Dacic, S., Chirieac, L. R., Galateau-Sallé, F., Fujimoto, J., Husain, A. N., Silveira, H. C., Rusch, V. W., Rintoul, R. C., Pass, H., Kindler, H., Zauderer, M. G., Kwiatkowski, D. J., Bueno, R., Tsao, A. S., Creaney, J., Lichtenberg, T., Leraas, K., Bowen, J., TCGA Research Network, Felau, I., Zenklusen, J. C., Akbani, R., Cherniack, A. D., Byers, L. A., Noble, M. S., Fletcher, J. A., Robertson, A. G., Shen, R., Aburatani, H., Robinson, B. W., Campbell, P., Ladanyi, M., Aburatani, H., Akbani, R., Ally, A., Anur, P., Armenia, J., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., Becich, M., Behrens, C., Beroukhim, R., Bielski, C., Bodenheimer, T., Bootwalla, M. S., Bowen, J., Bowlby, R., Brooks, D., Bueno, R., Byers, L. A., Cárcano, F. M., Carlsen, R., Carvalho, A. L., Cherniack, A. D., Cheung, D., Chirieac, L., Cho, J., Chuah, E., Chudamani, S., Cibulskis, C., Cope, L., Crain, D., Creaney, J., Curley, E., Dacic, S., Danilova, L., Rienzo, A. D., DeFreitas, T., Demchok, J. A., Dhalla, N., Dhir, R., Diao, L., Drill, E., Felau, I., Feldman, M., Ferguson, M. L., Fletcher, J. A., Fujimoto, J., Fujimoto, J., Fukuda, S., Gabriel, S. B., Sallé, F. G., Gao, J., Gardner, J., Gastier-Foster, J. M., Gay, C. M., Gehlenborg, N., Gerken, M., Getz, G., Gibb, E. A., Gibbs, D. L., Goparaju, C., Graim, K., Gross, B., Guo, G., Gupta, M., Hasegawa, S., Haussler, D., Hayes, D. N., Heiman, D. I., Heins, Z., Hmeljak, J., Hoadley, K. A., Holt, R. A., Hoyle, A. P., Husain, A., Hutter, C. M., Iype, L., Jefferys, S. R., Jones, S. J. M., Jones, C. D., Kanchi, R. S., Kasaian, K., Kim, J., Kindler, H., Kondo, N., Krausz, T., Kundra, R., Kuribayashi, K., Kwiatkowski, D. J., Ladanyi, M., Lai, P. H., Laird, P. W., Lawrence, M. S., Lee, D., Leraas, K. M., Lichtenberg, T. M., Lin, P., Liu, J., Liu, W., Liu, E. M., Lolla, L., Longatto-Filho, A., Lu, Y., Luketich, J., Ma, Y., Maglinte, D. T., Mallory, D., Marra, M. A., Mayo, M., Meier, S., Melamed, J., Meng, S., Meyerson, M., Mieczkowski, P. A., Mills, G. B., Moore, R. A., Moran, C., Morris, S., Mose, L. E., Mungall, A. J., Mungall, K., Nakano, T., Naresh, R., Newton, Y., Noble, M. S., Ochoa, A., Osmanbeyoglu, H., Parker, J. S., Pass, H. I., Paulauskis, J., Pennathur, A., Pennell, N. A., Penny, R., Perou, C. M., Pihl, T., Ramirez, N. C., Rassl, D. M., Ravegnini, G., Reid, G., Reis, R. M., Reynolds, S. M., Rice, D., Richards, W. G., Rintoul, R. C., Roach, J., Robertson, A. G., Rusch, V., Sadeghi, S., Saksena, G., Sanchez-Vega, F., Sander, C., Sato, A., Scapulatempo-Neto, C., Schein, J. E., Schultz, N., Schumacher, S. E., Seiwert, T., Sekido, Y., Severson, D. T., Shelton, C., Shelton, T., Shen, R., Sheridan, R., Shi, Y., Shih, J., Shiraishi, Y., Shmulevich, I., Silveira, H. C. S., Simons, J. V., Sipahimalani, P., Skelly, T., Sofia, H. J., Soloway, M. G., Spellman, P., Stewart, C., Stuart, J., Sun, Q., Takeshita, J., Tam, A., Tan, D., Tarnuzzer, R., Tatsuno, K., Taylor, B. S., Thiessen, N., Thompson, E., Thorsson, V., Travis, W. D., Tsao, A., Tse, K., Tsujimura, T., Valdivieso, F., Van Den Berg, D. J., van Zandwijk, N., Veluvolu, U., Viana, L. S., Voet, D., Wan, Y., Wang, Z., Wang, J., Weaver, J., Weinstein, J. N., Weisenberger, D. J., Wilkerson, M. D., Wise, L., Wistuba, I., Wong, T., Wu, Y., Yamamoto, S., Yang, L., Zauderer, M. G., Zenklusen, J. C., Zhang, J., Zhang, H., Zhang, H., & Zmuda, E.
- Affiliations
- 3Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- Wellcome Sanger Institute (GB)
- 10Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 11Computational Systems Biology, Memorial Sloan Kettering Cancer Center, New York, New York.
- The University of Texas at Dallas (US)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Memorial Sloan Kettering Cancer Center (US)
- 23Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
- 24MESOPATH. Cancer Center Leon Berard, Lyon, France.
- 26Department of Pathology, University of Chicago, Chicago, Illinois.
- 27Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil.
- 28Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
- 30Department of Cardiothoracic Surgery, NYU Langone Medical Center, New York, New York.
- 15Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 35The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
- 36National Cancer Institute, Bethesda, Maryland.
- 18Division of Thoracic Surgery, The Lung Center and International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts.
- The University of Western Australia (AU)
- ORCID
- Tarpey, Patrick
- Kantheti, Havish
- Desmeules, Patrice
- Jungbluth, Achim A.
- Silveira, Henrique C.
- Tsao, Anne S.
- Robinson, Bruce W.
- Campbell, Peter
- Armenia, Joshua
- Auman, J. Todd
- Baylin, Stephen B.
- Becich, Michael
- Behrens, Carmen
- Beroukhim, Rameen
- Bootwalla, Moiz S.
- Cibulskis, Carrie
- Cope, Leslie
- Rienzo, Assunta De
- Dhir, Rajiv
- Ferguson, Martin L.
- Fukuda, Shiro
- Gabriel, Stacey B.
- Gao, Jianjiong
- Gehlenborg, Nils
- Getz, Gad
- Goparaju, Chandra
- Gross, Benjamin
- Guo, Guangwu
- Hasegawa, Seiki
- Haussler, David
- Hayes, D. Neil
- Heins, Zachary
- Holt, Robert A.
- Hoyle, Alan P.
- Jefferys, Stuart R.
- Jones, Steven J.M.
- Jones, Corbin D.
- Kasaian, Katayoon
- Kim, Jaegil
- Kondo, Nobuyuki
- Kundra, Ritika
- Kuribayashi, Kozo
- Laird, Peter W.
- Lawrence, Michael S.
- Lee, Darlene
- Lin, Pei
- Liu, Jia
- Liu, Wenbin
- Liu, Eric Minwei
- Lu, Yiling
- Luketich, James
- Maglinte, Dennis T.
- Marra, Marco A.
- Mayo, Michael
- Melamed, Jonathan
- Meyerson, Matthew
- Mieczkowski, Piotr A.
- Mills, Gordon B.
- Mungall, Andrew J.
- Nakano, Takashi
- Ochoa, Angelica
- Parker, Joel S.
- Pennathur, Arjun
- Pennell, Nathan A.
- Perou, Charles M.
- Pihl, Todd
- Ramirez, Nilsa C.
- Rassl, Doris M.
- Reid, Glen
- Reis, Rui M.
- Rice, David
- Richards, William G
- Roach, Jeffrey
- Sadeghi, Sara
- Saksena, Gordon
- Sander, Chris
- Sato, Ayuko
- Schultz, Nikolaus
- Schumacher, Steven E.
- Seiwert, Tanguy
- Shi, Yan
- Shiraishi, Yuichi
- Sofia, Heidi J.
- Spellman, Paul
- Sun, Qiang
- Tam, Angela
- Tarnuzzer, Roy
- Tatsuno, Kenji
- Taylor, Barry S
- Tsujimura, Tohru
- Wang, Jing
- Weaver, Joellen
- Weinstein, John N.
- Weisenberger, Daniel J.
- Wilkerson, Matthew D.
- Wistuba, Ignacio
- Wong, Tina
- Wu, Ye
- Yamamoto, Shogo
- Yang, Liming
- Zhang, Jiashan
- Zhang, Hailei
- Zhang, Hongxin
- Zmuda, Erik
- Venue
- Cancer Discovery
- Published
- 2018-12-01
- Volume
- 8
- Issue
- 12
- Pages
- 1548-1565
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC6310008
- OpenAlex
- W2897299514
- Cited by
- 618
- References
- 62
- Citations by year
- 2026: 53 · 2025: 62 · 2024: 61 · 2023: 78 · 2022: 96 · 2021: 117 · 2020: 100 · 2019: 45 · 2018: 4
- FWCI
- 50.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
- Funders
- HHS | National Institutes of Health (NIH) (U54 HG003273, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, P30 CA016672, P30 CA008748, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848)
- British Lung Foundation (BLF) (APG11-7)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- malignant pleural mesothelioma, TP53 mutation, loss of heterozygosity, genomic subtypes, VISTA, immune checkpoint, epithelioid mesothelioma, immunotherapy, antitumor immunity
- MeSH terms
- Aged, Female, Humans, Lung Neoplasms, Male, Mesothelioma, Middle Aged, Mutation, Pleural Neoplasms, Prognosis, Histone-Lysine N-Methyltransferase, Protein Methyltransferases, Biomarkers, Tumor, Tumor Suppressor Proteins, Ubiquitin Thiolesterase, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.